<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2004-12-21" modified="2020-10-07" version="170">
<accession>Q8IVT5</accession>
<accession>F8WEA9</accession>
<accession>H7BYU0</accession>
<accession>Q13476</accession>
<name>KSR1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Kinase suppressor of Ras 1</fullName>
<ecNumber evidence="9">2.7.11.1</ecNumber>
</recommendedName>
</protein>
<gene>
<name type="primary">KSR1</name>
<name type="synonym">KSR</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2006" name="Nature" volume="440" first="1045" last="1049">
<title>DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage.</title>
<authorList>
<person name="Zody M.C."/>
<person name="Garber M."/>
<person name="Adams D.J."/>
<person name="Sharpe T."/>
<person name="Harrow J."/>
<person name="Lupski J.R."/>
<person name="Nicholson C."/>
<person name="Searle S.M."/>
<person name="Wilming L."/>
<person name="Young S.K."/>
<person name="Abouelleil A."/>
<person name="Allen N.R."/>
<person name="Bi W."/>
<person name="Bloom T."/>
<person name="Borowsky M.L."/>
<person name="Bugalter B.E."/>
<person name="Butler J."/>
<person name="Chang J.L."/>
<person name="Chen C.-K."/>
<person name="Cook A."/>
<person name="Corum B."/>
<person name="Cuomo C.A."/>
<person name="de Jong P.J."/>
<person name="DeCaprio D."/>
<person name="Dewar K."/>
<person name="FitzGerald M."/>
<person name="Gilbert J."/>
<person name="Gibson R."/>
<person name="Gnerre S."/>
<person name="Goldstein S."/>
<person name="Grafham D.V."/>
<person name="Grocock R."/>
<person name="Hafez N."/>
<person name="Hagopian D.S."/>
<person name="Hart E."/>
<person name="Norman C.H."/>
<person name="Humphray S."/>
<person name="Jaffe D.B."/>
<person name="Jones M."/>
<person name="Kamal M."/>
<person name="Khodiyar V.K."/>
<person name="LaButti K."/>
<person name="Laird G."/>
<person name="Lehoczky J."/>
<person name="Liu X."/>
<person name="Lokyitsang T."/>
<person name="Loveland J."/>
<person name="Lui A."/>
<person name="Macdonald P."/>
<person name="Major J.E."/>
<person name="Matthews L."/>
<person name="Mauceli E."/>
<person name="McCarroll S.A."/>
<person name="Mihalev A.H."/>
<person name="Mudge J."/>
<person name="Nguyen C."/>
<person name="Nicol R."/>
<person name="O'Leary S.B."/>
<person name="Osoegawa K."/>
<person name="Schwartz D.C."/>
<person name="Shaw-Smith C."/>
<person name="Stankiewicz P."/>
<person name="Steward C."/>
<person name="Swarbreck D."/>
<person name="Venkataraman V."/>
<person name="Whittaker C.A."/>
<person name="Yang X."/>
<person name="Zimmer A.R."/>
<person name="Bradley A."/>
<person name="Hubbard T."/>
<person name="Birren B.W."/>
<person name="Rogers J."/>
<person name="Lander E.S."/>
<person name="Nusbaum C."/>
</authorList>
<dbReference type="PubMed" id="16625196"/>
<dbReference type="DOI" id="10.1038/nature04689"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-628 (ISOFORM 3)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1995" name="Cell" volume="83" first="879" last="888">
<title>KSR, a novel protein kinase required for RAS signal transduction.</title>
<authorList>
<person name="Therrien M."/>
<person name="Chang H.C."/>
<person name="Solomon N.M."/>
<person name="Karim F.D."/>
<person name="Wassarman D.A."/>
<person name="Rubin G.M."/>
</authorList>
<dbReference type="PubMed" id="8521512"/>
<dbReference type="DOI" id="10.1016/0092-8674(95)90204-x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 243-899 (ISOFORM 2)</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1999" name="Mol. Cell. Biol." volume="19" first="5523" last="5534">
<title>Kinase suppressor of Ras forms a multiprotein signaling complex and modulates MEK localization.</title>
<authorList>
<person name="Stewart S."/>
<person name="Sundaram M."/>
<person name="Zhang Y."/>
<person name="Lee J."/>
<person name="Han M."/>
<person name="Guan K.L."/>
</authorList>
<dbReference type="PubMed" id="10409742"/>
<dbReference type="DOI" id="10.1128/mcb.19.8.5523"/>
</citation>
<scope>INTERACTION WITH MAP2K1; MAP2K2; HSP90AA1; 14-3-3 AND CDC37</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2002" name="Curr. Biol." volume="12" first="R325" last="R327">
<title>MAP kinase module: the Ksr connection.</title>
<authorList>
<person name="Roy F."/>
<person name="Therrien M."/>
</authorList>
<dbReference type="PubMed" id="12007434"/>
<dbReference type="DOI" id="10.1016/s0960-9822(02)00831-x"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-311</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="1346" last="1351">
<title>Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.</title>
<authorList>
<person name="Cantin G.T."/>
<person name="Yi W."/>
<person name="Lu B."/>
<person name="Park S.K."/>
<person name="Xu T."/>
<person name="Lee J.-D."/>
<person name="Yates J.R. III"/>
</authorList>
<dbReference type="PubMed" id="18220336"/>
<dbReference type="DOI" id="10.1021/pr0705441"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-270 AND SER-334</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="526" last="534">
<title>Phosphoproteome of resting human platelets.</title>
<authorList>
<person name="Zahedi R.P."/>
<person name="Lewandrowski U."/>
<person name="Wiesner J."/>
<person name="Wortelkamp S."/>
<person name="Moebius J."/>
<person name="Schuetz C."/>
<person name="Walter U."/>
<person name="Gambaryan S."/>
<person name="Sickmann A."/>
</authorList>
<dbReference type="PubMed" id="18088087"/>
<dbReference type="DOI" id="10.1021/pr0704130"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-270</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Platelet</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-270; THR-274; SER-334; SER-406 AND SER-569</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.m800588-mcp200"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-406</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="12">
<citation type="journal article" date="2010" name="Mol. Cell. Biol." volume="30" first="4687" last="4697">
<title>VRK2 inhibits mitogen-activated protein kinase signaling and inversely correlates with ErbB2 in human breast cancer.</title>
<authorList>
<person name="Fernandez I.F."/>
<person name="Blanco S."/>
<person name="Lozano J."/>
<person name="Lazo P.A."/>
</authorList>
<dbReference type="PubMed" id="20679487"/>
<dbReference type="DOI" id="10.1128/mcb.01581-09"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH VRK2</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2010" name="Nat. Cell Biol." volume="12" first="1242" last="1249">
<title>AKAP-Lbc enhances cyclic AMP control of the ERK1/2 cascade.</title>
<authorList>
<person name="Smith F.D."/>
<person name="Langeberg L.K."/>
<person name="Cellurale C."/>
<person name="Pawson T."/>
<person name="Morrison D.K."/>
<person name="Davis R.J."/>
<person name="Scott J.D."/>
</authorList>
<dbReference type="PubMed" id="21102438"/>
<dbReference type="DOI" id="10.1038/ncb2130"/>
</citation>
<scope>INTERACTION WITH AKAP13 AND BRAF</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-311</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-270; THR-274; SER-311; SER-334; SER-351; SER-406; THR-425 AND SER-569</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="17" evidence="1">
<citation type="journal article" date="2018" name="Nature" volume="554" first="549" last="553">
<title>MEK drives BRAF activation through allosteric control of KSR proteins.</title>
<authorList>
<person name="Lavoie H."/>
<person name="Sahmi M."/>
<person name="Maisonneuve P."/>
<person name="Marullo S.A."/>
<person name="Thevakumaran N."/>
<person name="Jin T."/>
<person name="Kurinov I."/>
<person name="Sicheri F."/>
<person name="Therrien M."/>
</authorList>
<dbReference type="PubMed" id="29433126"/>
<dbReference type="DOI" id="10.1038/nature25478"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 27-172</scope>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>INTERACTION WITH BRAF; MAP2K1; MAP2K2; HSP90AA1; 14-3-3 AND CDC37</scope>
<scope>DOMAIN</scope>
<scope>MUTAGENESIS OF LEU-47; CYS-62; GLU-72; 602-TYR--GLN-604; ALA-637; ARG-639; ARG-665 AND TRP-831</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] PRO-227; ALA-359 AND HIS-663</scope>
</reference>
<comment type="function">
<text evidence="9 19">Part of a multiprotein signaling complex which promotes phosphorylation of Raf family members and activation of downstream MAP kinases (By similarity). Independently of its kinase activity, acts as MAP2K1/MEK1 and MAP2K2/MEK2-dependent allosteric activator of BRAF; upon binding to MAP2K1/MEK1 or MAP2K2/MEK2, dimerizes with BRAF and promotes BRAF-mediated phosphorylation of MAP2K1/MEK1 and/or MAP2K2/MEK2 (PubMed:29433126). Promotes activation of MAPK1 and/or MAPK3, both in response to EGF and to cAMP (By similarity). Its kinase activity is unsure (By similarity). Some protein kinase activity has been detected in vitro, however the physiological relevance of this activity is unknown (By similarity).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="9">
<text>ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-[protein]</text>
<dbReference type="Rhea" id="RHEA:17989"/>
<dbReference type="Rhea" id="RHEA-COMP:9863"/>
<dbReference type="Rhea" id="RHEA-COMP:11604"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:29999"/>
<dbReference type="ChEBI" id="CHEBI:30616"/>
<dbReference type="ChEBI" id="CHEBI:83421"/>
<dbReference type="ChEBI" id="CHEBI:456216"/>
<dbReference type="EC" id="2.7.11.1"/>
</reaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="9">
<text>ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-threonyl-[protein]</text>
<dbReference type="Rhea" id="RHEA:46608"/>
<dbReference type="Rhea" id="RHEA-COMP:11060"/>
<dbReference type="Rhea" id="RHEA-COMP:11605"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:30013"/>
<dbReference type="ChEBI" id="CHEBI:30616"/>
<dbReference type="ChEBI" id="CHEBI:61977"/>
<dbReference type="ChEBI" id="CHEBI:456216"/>
<dbReference type="EC" id="2.7.11.1"/>
</reaction>
</comment>
<comment type="subunit">
<text evidence="9 15 17 18 19">Homodimer (PubMed:29433126). Heterodimerizes (via N-terminus) with BRAF (via N-terminus) in a MAP2K1/MEK1 or MAP2K2/MEK2-dependent manner (PubMed:29433126). Interacts with MAP2K1/MEK1 and MAP2K2/MEK2 (PubMed:10409742, PubMed:29433126). Binding to MAP2K1/MEK1 releases the intramolecular inhibitory interaction between KSR1 N-terminus and kinase domains which is required for the subsequent RSK1 dimerization with BRAF (PubMed:29433126). Identified in a complex with AKAP13, MAP2K1 and BRAF (By similarity). Interacts with AKAP13 and BRAF (PubMed:21102438). Interacts with RAF and MAPK/ERK, in a Ras-dependent manner (By similarity). Interacts with 14-3-3 proteins including YWHAB (By similarity). Interacts with HSP90AA1/HSP90, YWHAE/14-3-3 and CDC37 (PubMed:10409742, PubMed:29433126). The binding of 14-3-3 proteins to phosphorylated KSR1 prevents the membrane localization (By similarity). Interacts with MARK3 (By similarity). Interacts with PPP2R1A and PPP2CA (By similarity). Interacts with isoform 1 of VRK2 (PubMed:20679487).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-486984">
<id>Q8IVT5</id>
</interactant>
<interactant intactId="EBI-1056930">
<id>P36507</id>
<label>MAP2K2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-486984">
<id>Q8IVT5</id>
</interactant>
<interactant intactId="EBI-1207615">
<id>Q86Y07</id>
<label>VRK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="17">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="17">Membrane</location>
<topology evidence="17">Peripheral membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="9">Cell membrane</location>
<topology evidence="9">Peripheral membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="9">Cell projection</location>
<location evidence="9">Ruffle membrane</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="17">Endoplasmic reticulum membrane</location>
</subcellularLocation>
<text evidence="23">In unstimulated cells, where the phosphorylated form is bound to a 14-3-3 protein, sequestration in the cytoplasm occurs. Following growth factor treatment, the protein is free for membrane translocation, and it moves from the cytoplasm to the cell periphery.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q8IVT5-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q8IVT5-2</id>
<name>2</name>
<sequence type="described" ref="VSP_055656 VSP_055657"/>
</isoform>
<isoform>
<id>Q8IVT5-3</id>
<name>3</name>
<sequence type="described" ref="VSP_055655"/>
</isoform>
<isoform>
<id>Q8IVT5-4</id>
<name>4</name>
<sequence type="described" ref="VSP_055655 VSP_055657"/>
</isoform>
</comment>
<comment type="domain">
<text evidence="11 15">The protein kinase domain is predicted to be catalytically inactive. The domain is sufficient for KSR1 and KSR1-mediated MAP2K1 and MAP2K2 membrane localization. The domain is required but not sufficient for MAP kinase-mediated inhibition of ELK1 phosphorylation (PubMed:10409742).</text>
</comment>
<comment type="domain">
<text evidence="9 19">The N-terminal region mediates interaction with BRAF (PubMed:29433126). Also mediates membrane localization (By similarity).</text>
</comment>
<comment type="PTM">
<text evidence="9">Phosphorylated on Ser-311 and, to a higher extent, on Ser-406 by MARK3. Dephosphorylated on Ser-406 by PPP2CA. In resting cells, phosphorylated KSR1 is cytoplasmic and in stimulated cells, dephosphorylated KSR1 is membrane-associated. Phosphorylated by PKA at Ser-888. Phosphorylation at Ser-888 is required for cAMP-dependent activation of MAPK1 and/or MAPK3 (By similarity).</text>
</comment>
<comment type="similarity">
<text evidence="22">Belongs to the protein kinase superfamily. TKL Ser/Thr protein kinase family.</text>
</comment>
<comment type="caution">
<text evidence="9 19 22">Although it belongs to the protein kinase superfamily, the ATP-binding motif VAIK has an arginine instead of a lysine residue suggesting that KSR1 can not bind ATP and therefore lacks protein kinase activity. However, KSR1 is capable of binding ATP (PubMed:29433126). Has protein kinase activity towards MAP2K1 in the presence of RAF1/c-RAF in vitro (By similarity).</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/KSR1ID41107ch17q11.html"/>
</comment>
<dbReference type="EC" id="2.7.11.1" evidence="9"/>
<dbReference type="EMBL" id="AC069366">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC015688">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC042106">
<property type="protein sequence ID" value="AAH42106.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U43586">
<property type="protein sequence ID" value="AAC50354.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS58532.1">
<molecule id="Q8IVT5-4"/>
</dbReference>
<dbReference type="RefSeq" id="NP_055053.1">
<molecule id="Q8IVT5-4"/>
<property type="nucleotide sequence ID" value="NM_014238.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011523731.1">
<molecule id="Q8IVT5-1"/>
<property type="nucleotide sequence ID" value="XM_011525429.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016880760.1">
<molecule id="Q8IVT5-3"/>
<property type="nucleotide sequence ID" value="XM_017025271.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016880761.1">
<molecule id="Q8IVT5-3"/>
<property type="nucleotide sequence ID" value="XM_017025272.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016880762.1">
<molecule id="Q8IVT5-3"/>
<property type="nucleotide sequence ID" value="XM_017025273.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016880763.1">
<molecule id="Q8IVT5-3"/>
<property type="nucleotide sequence ID" value="XM_017025274.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016880764.1">
<molecule id="Q8IVT5-3"/>
<property type="nucleotide sequence ID" value="XM_017025275.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016880765.1">
<molecule id="Q8IVT5-3"/>
<property type="nucleotide sequence ID" value="XM_017025276.1"/>
</dbReference>
<dbReference type="PDB" id="5VYK">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.75"/>
<property type="chains" value="A/C=27-172"/>
</dbReference>
<dbReference type="PDBsum" id="5VYK"/>
<dbReference type="SMR" id="Q8IVT5"/>
<dbReference type="BioGRID" id="114371">
<property type="interactions" value="108"/>
</dbReference>
<dbReference type="CORUM" id="Q8IVT5"/>
<dbReference type="DIP" id="DIP-32619N"/>
<dbReference type="IntAct" id="Q8IVT5">
<property type="interactions" value="358"/>
</dbReference>
<dbReference type="MINT" id="Q8IVT5"/>
<dbReference type="STRING" id="9606.ENSP00000381958"/>
<dbReference type="ChEMBL" id="CHEMBL1938215"/>
<dbReference type="iPTMnet" id="Q8IVT5"/>
<dbReference type="PhosphoSitePlus" id="Q8IVT5"/>
<dbReference type="BioMuta" id="KSR1"/>
<dbReference type="DMDM" id="56749095"/>
<dbReference type="EPD" id="Q8IVT5"/>
<dbReference type="jPOST" id="Q8IVT5"/>
<dbReference type="MassIVE" id="Q8IVT5"/>
<dbReference type="MaxQB" id="Q8IVT5"/>
<dbReference type="PaxDb" id="Q8IVT5"/>
<dbReference type="PeptideAtlas" id="Q8IVT5"/>
<dbReference type="PRIDE" id="Q8IVT5"/>
<dbReference type="ProteomicsDB" id="31779"/>
<dbReference type="ProteomicsDB" id="43732"/>
<dbReference type="ProteomicsDB" id="70766">
<molecule id="Q8IVT5-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="70767">
<molecule id="Q8IVT5-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="70768">
<molecule id="Q8IVT5-3"/>
</dbReference>
<dbReference type="Antibodypedia" id="2110">
<property type="antibodies" value="410 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="8844"/>
<dbReference type="Ensembl" id="ENST00000398988">
<molecule id="Q8IVT5-4"/>
<property type="protein sequence ID" value="ENSP00000381958"/>
<property type="gene ID" value="ENSG00000141068"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000509603">
<molecule id="Q8IVT5-4"/>
<property type="protein sequence ID" value="ENSP00000438795"/>
<property type="gene ID" value="ENSG00000141068"/>
</dbReference>
<dbReference type="GeneID" id="8844"/>
<dbReference type="KEGG" id="hsa:8844"/>
<dbReference type="UCSC" id="uc002gzo.2">
<molecule id="Q8IVT5-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="8844"/>
<dbReference type="DisGeNET" id="8844"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000141068.13"/>
<dbReference type="GeneCards" id="KSR1"/>
<dbReference type="HGNC" id="HGNC:6465">
<property type="gene designation" value="KSR1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000141068">
<property type="expression patterns" value="Tissue enhanced (pancreas)"/>
</dbReference>
<dbReference type="MIM" id="601132">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q8IVT5"/>
<dbReference type="OpenTargets" id="ENSG00000141068"/>
<dbReference type="PharmGKB" id="PA30254"/>
<dbReference type="eggNOG" id="KOG0193">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000156066"/>
<dbReference type="InParanoid" id="Q8IVT5"/>
<dbReference type="KO" id="K14958"/>
<dbReference type="OrthoDB" id="281487at2759"/>
<dbReference type="PhylomeDB" id="Q8IVT5"/>
<dbReference type="TreeFam" id="TF317006"/>
<dbReference type="PathwayCommons" id="Q8IVT5"/>
<dbReference type="Reactome" id="R-HSA-5673000">
<property type="pathway name" value="RAF activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5674135">
<property type="pathway name" value="MAP2K and MAPK activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5675221">
<property type="pathway name" value="Negative regulation of MAPK pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6802946">
<property type="pathway name" value="Signaling by moderate kinase activity BRAF mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6802948">
<property type="pathway name" value="Signaling by high-kinase activity BRAF mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6802952">
<property type="pathway name" value="Signaling by BRAF and RAF fusions"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6802955">
<property type="pathway name" value="Paradoxical activation of RAF signaling by kinase inactive BRAF"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9649948">
<property type="pathway name" value="Signaling downstream of RAS mutants"/>
</dbReference>
<dbReference type="SignaLink" id="Q8IVT5"/>
<dbReference type="SIGNOR" id="Q8IVT5"/>
<dbReference type="BioGRID-ORCS" id="8844">
<property type="hits" value="7 hits in 899 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="KSR1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="KSR1"/>
<dbReference type="GenomeRNAi" id="8844"/>
<dbReference type="Pharos" id="Q8IVT5">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q8IVT5"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 17"/>
</dbReference>
<dbReference type="RNAct" id="Q8IVT5">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000141068">
<property type="expression patterns" value="Expressed in body of pancreas and 211 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q8IVT5">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q8IVT5">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005783">
<property type="term" value="C:endoplasmic reticulum"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005789">
<property type="term" value="C:endoplasmic reticulum membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0032991">
<property type="term" value="C:protein-containing complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0032587">
<property type="term" value="C:ruffle membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0071889">
<property type="term" value="F:14-3-3 protein binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051087">
<property type="term" value="F:chaperone binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051879">
<property type="term" value="F:Hsp90 protein binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005078">
<property type="term" value="F:MAP-kinase scaffold activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0031434">
<property type="term" value="F:mitogen-activated protein kinase kinase binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008022">
<property type="term" value="F:protein C-terminus binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0004672">
<property type="term" value="F:protein kinase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0004674">
<property type="term" value="F:protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0000185">
<property type="term" value="P:activation of MAPKKK activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019933">
<property type="term" value="P:cAMP-mediated signaling"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000165">
<property type="term" value="P:MAPK cascade"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043410">
<property type="term" value="P:positive regulation of MAPK cascade"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007265">
<property type="term" value="P:Ras protein signal transduction"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042127">
<property type="term" value="P:regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043405">
<property type="term" value="P:regulation of MAP kinase activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="CDD" id="cd00029">
<property type="entry name" value="C1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.150.50">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR025561">
<property type="entry name" value="KSR_SAM-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR002219">
<property type="entry name" value="PE/DAG-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR013761">
<property type="entry name" value="SAM/pointed_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR001245">
<property type="entry name" value="Ser-Thr/Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR008271">
<property type="entry name" value="Ser/Thr_kinase_AS"/>
</dbReference>
<dbReference type="Pfam" id="PF07714">
<property type="entry name" value="PK_Tyr_Ser-Thr"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF13543">
<property type="entry name" value="SAM_KSR1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00109">
<property type="entry name" value="C1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00220">
<property type="entry name" value="S_TKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00108">
<property type="entry name" value="PROTEIN_KINASE_ST"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00479">
<property type="entry name" value="ZF_DAG_PE_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50081">
<property type="entry name" value="ZF_DAG_PE_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0966">Cell projection</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0256">Endoplasmic reticulum</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="chain" description="Kinase suppressor of Ras 1" id="PRO_0000086229">
<location>
<begin position="1"/>
<end position="923"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="12">
<location>
<begin position="613"/>
<end position="883"/>
</location>
</feature>
<feature type="zinc finger region" description="Phorbol-ester/DAG-type" evidence="13">
<location>
<begin position="347"/>
<end position="391"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="12">
<location>
<begin position="619"/>
<end position="627"/>
</location>
</feature>
<feature type="region of interest" description="Mediates association with membranes" evidence="9">
<location>
<begin position="1"/>
<end position="172"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gly">
<location>
<begin position="17"/>
<end position="21"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Pro">
<location>
<begin position="289"/>
<end position="292"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="14">
<location>
<position position="733"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1" evidence="9">
<location>
<position position="348"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2" evidence="9">
<location>
<position position="360"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2" evidence="9">
<location>
<position position="363"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1" evidence="9">
<location>
<position position="373"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1" evidence="9">
<location>
<position position="376"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2" evidence="9">
<location>
<position position="381"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2" evidence="9">
<location>
<position position="384"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1" evidence="9">
<location>
<position position="391"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="10">
<location>
<position position="735"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="10">
<location>
<position position="750"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="3 4 5 8">
<location>
<position position="270"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="5 8">
<location>
<position position="274"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 7 8">
<location>
<position position="311"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 5 8">
<location>
<position position="334"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="351"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 6 8">
<location>
<position position="406"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="8">
<location>
<position position="425"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 8">
<location>
<position position="569"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="888"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3 and isoform 4." id="VSP_055655" evidence="20">
<location>
<begin position="1"/>
<end position="137"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_055656" evidence="21">
<original>VPSAGHCWKCLLIAESLKENAFN</original>
<variation>D</variation>
<location>
<begin position="504"/>
<end position="526"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2 and isoform 4." id="VSP_055657" evidence="21">
<original>DINSSKVVPRFERFGLGVLESSNPKM</original>
<variation>EL</variation>
<location>
<begin position="898"/>
<end position="923"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_040658" evidence="16">
<original>S</original>
<variation>P</variation>
<location>
<position position="227"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_046048" evidence="16">
<original>V</original>
<variation>A</variation>
<location>
<position position="359"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_046049" evidence="16">
<original>Q</original>
<variation>H</variation>
<location>
<position position="663"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces interaction with BRAF and MAP2K1 and thus phosphorylation of MAP2K1." evidence="19">
<original>L</original>
<variation>D</variation>
<location>
<position position="47"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces interaction with BRAF and MAP2K1 and thus phosphorylation of MAP2K1." evidence="19">
<original>C</original>
<variation>D</variation>
<location>
<position position="62"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with BRAF and MAP2K1 and severe decrease in MAP2K1 phosphorylation levels." evidence="19">
<original>E</original>
<variation>K</variation>
<location>
<position position="72"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on MAP2K1- or MAP2K2-mediated-BRAF-KSR1 dimerization and BRAF activation." evidence="19">
<original>YLQ</original>
<variation>DDE</variation>
<location>
<begin position="602"/>
<end position="604"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on MAP2K1 or MAP2K2 mediated-BRAF-KSR1 dimerization and BRAF activation." evidence="19">
<original>A</original>
<variation>F</variation>
<location>
<position position="637"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on MAP2K1 mediated-BRAF-KSR1 dimerization and BRAF activation." evidence="19">
<original>R</original>
<variation>M</variation>
<location>
<position position="639"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of MAP2K1 mediated-BRAF-KSR1 dimerization." evidence="19">
<original>R</original>
<variation>H</variation>
<location>
<position position="665"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of the interaction with MAP2K1 resulting in loss of BRAF-KSR1 dimerization and BRAF activation. No effect on ATP binding or interaction with HSP90AA1, 14-3-3 and CDC37." evidence="19">
<original>W</original>
<variation>R</variation>
<location>
<position position="831"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAH42106." ref="3" evidence="22">
<original>FSEGLSDTCIPLHASGRLTPRAL</original>
<variation>EFRHTSALTQHTAHTQHTSAHTQ</variation>
<location>
<begin position="243"/>
<end position="265"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="34"/>
<end position="61"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="67"/>
<end position="93"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="101"/>
<end position="104"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="109"/>
<end position="115"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="120"/>
<end position="124"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="132"/>
<end position="137"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="140"/>
<end position="149"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="154"/>
<end position="170"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5VYK"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18088087"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18220336"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q61097"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q6VAB6"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000255"/>
<evidence key="12" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00226"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10027"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10409742"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20679487"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21102438"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29433126"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8521512"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000305"/>
<evidence key="23" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="12007434"/>
</source>
</evidence>
<sequence length="923" mass="102160" checksum="61BF0F1598349540" modified="2014-09-03" version="3">MDRAALRAAAMGEKKEGGGGGDAAAAEGGAGAAASRALQQCGQLQKLIDISIGSLRGLRTKCAVSNDLTQQEIRTLEAKLVRYICKQRQCKLSVAPGERTPELNSYPRFSDWLYTFNVRPEVVQEIPRDLTLDALLEMNEAKVKETLRRCGASGDECGRLQYALTCLRKVTGLGGEHKEDSSWSSLDARRESGSGPSTDTLSAASLPWPPGSSQLGRAGNSAQGPRSISVSALPASDSPTPSFSEGLSDTCIPLHASGRLTPRALHSFITPPTTPQLRRHTKLKPPRTPPPPSRKVFQLLPSFPTLTRSKSHESQLGNRIDDVSSMRFDLSHGSPQMVRRDIGLSVTHRFSTKSWLSQVCHVCQKSMIFGVKCKHCRLKCHNKCTKEAPACRISFLPLTRLRRTESVPSDINNPVDRAAEPHFGTLPKALTKKEHPPAMNHLDSSSNPSSTTSSTPSSPAPFPTSSNPSSATTPPNPSPGQRDSRFNFPAAYFIHHRQQFIFPVPSAGHCWKCLLIAESLKENAFNISAFAHAAPLPEAADGTRLDDQPKADVLEAHEAEAEEPEAGKSEAEDDEDEVDDLPSSRRPWRGPISRKASQTSVYLQEWDIPFEQVELGEPIGQGRWGRVHRGRWHGEVAIRLLEMDGHNQDHLKLFKKEVMNYRQTRHENVVLFMGACMNPPHLAIITSFCKGRTLHSFVRDPKTSLDINKTRQIAQEIIKGMGYLHAKGIVHKDLKSKNVFYDNGKVVITDFGLFGISGVVREGRRENQLKLSHDWLCYLAPEIVREMTPGKDEDQLPFSKAADVYAFGTVWYELQARDWPLKNQAAEASIWQIGSGEGMKRVLTSVSLGKEVSEILSACWAFDLQERPSFSLLMDMLEKLPKLNRRLSHPGHFWKSADINSSKVVPRFERFGLGVLESSNPKM</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

